Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

VANI.US Logo

VANI.US - Current Price

$1.28

Company Information

▼
Company Name
Vivani Medical Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US92854B1098
CIK: 0001266806
CUSIP: 92854B109
Currency: USD
Full Time Employees: 37
Phone: 415 506 8462
Website: https://www.vivani.com
Fiscal Year End: December
IPO Date: Nov 19, 2014
Description:

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in clinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature and subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant for metabolic diseases in cats. The company is headquartered in Alameda, California.

Address:

1350 South Loop Road, Alameda, CA, United States, 94502

Directors & Officers

▼
Name Title Year Born
Dr. Adam Mendelsohn Ph.D. Co-Founder, CEO & Director 1983
Mr. Truc Le M.B.A. Chief Operations Officer 1953
Dr. Lisa E. Porter M.D. Chief Medical Officer 1964
Mr. Anthony Edward Baldor Chief Financial Officer NA
Mr. Donald Dwyer M.B.A. Chief Business Officer & Corporate Secretary 1960

Shares Statistics

▼
Shares Outstanding: 72.95M
Shares Float: 33.70M
% Insiders: 3,985.00%
% Institutions: 536.80%
Short % Float: 0.44%

Valuation Metrics

▼
Enterprise Value: $112.69M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $97.03M
EBITDA: $-26.81M
Book Value: $0.02
Earnings/Share: $-0.45
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -50.05%
ROE (TTM): -265.02%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 -0.09 N/A 10,000.00%
Sep 30, 2025 -0.11 -0.10 N/A -1,578.95%
Jun 30, 2025 -0.12 -0.10 N/A -2,000.00%
Mar 31, 2025 -0.11 -0.12 N/A 1,216.67%
Dec 31, 2024 -0.11 -0.11 N/A 0.00%
Sep 30, 2024 -0.11 -0.13 N/A 1,538.46%
Jun 30, 2024 -0.10 -0.12 N/A 1,666.67%
Mar 31, 2024 -0.12 -0.12 N/A 0.00%
Dec 31, 2023 -0.12 -0.14 N/A 1,428.57%
Sep 30, 2023 -0.13 -0.13 N/A 0.00%
Jun 30, 2023 -0.13 -0.11 N/A -1,818.18%
Mar 31, 2023 -0.12 -0.12 N/A 0.00%
Dec 31, 2022 -0.18 0.00 N/A N/A
Sep 30, 2022 0.04 0.00 N/A N/A
Jun 30, 2022 -0.08 N/A N/A N/A
Mar 31, 2022 -0.06 N/A N/A N/A
Dec 31, 2021 -0.06 -0.04 N/A -5,000.00%
Sep 30, 2021 -0.06 -0.35 N/A 8,285.71%
Jun 30, 2021 -0.06 -0.35 N/A 8,285.71%
Mar 31, 2021 -0.06 -0.44 N/A 8,636.36%
Dec 31, 2020 -0.06 -0.42 N/A 8,571.43%
Sep 30, 2020 -0.21 -0.41 N/A 4,878.05%
Jun 30, 2020 -0.45 -1.23 N/A 6,341.46%
Mar 31, 2020 -1.71 -1.23 N/A -3,902.44%
Dec 31, 2019 -1.50 -1.47 N/A -204.08%
Sep 30, 2019 -1.44 -1.44 N/A 0.00%
Jun 30, 2019 -1.68 -1.44 N/A -1,666.67%
Mar 31, 2019 -1.92 -1.44 N/A -3,333.33%
Dec 31, 2018 -2.88 -2.64 N/A -909.09%
Sep 30, 2018 -2.88 -3.36 N/A 1,428.57%
Jun 30, 2018 -2.88 -3.36 N/A 1,428.57%
Mar 31, 2018 -1.12 N/A N/A N/A
Dec 31, 2017 -3.12 -3.36 N/A 714.29%
Sep 30, 2017 -0.88 N/A N/A N/A
Jun 30, 2017 -2.88 -3.60 N/A 2,000.00%
Mar 31, 2017 -3.84 -3.36 N/A -1,428.57%
Dec 31, 2016 -5.76 -4.08 N/A -4,117.65%
Sep 30, 2016 -4.80 -3.84 N/A -2,500.00%
Jun 30, 2016 -4.56 -3.60 N/A -2,666.67%
Mar 31, 2016 -3.84 -3.84 N/A 0.00%
Dec 31, 2015 -3.60 -3.36 N/A -714.29%
Sep 30, 2015 -3.12 -3.36 N/A 714.29%
Jun 30, 2015 -0.13 -0.14 N/A 714.29%
Mar 31, 2015 -3.37 N/A N/A N/A
Dec 31, 2014 -11.04 N/A N/A N/A

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $18.35M $N/A $41.56M $23.95M $17.61M
2023-12-31 $20.65M $N/A $45.80M $25.04M $20.76M
2022-12-31 $45.08M $N/A $51.13M $6.82M $44.31M
2021-12-31 $2.18M $N/A $5.45M $2.99M $2.47M
2020-12-31 $2.08M $N/A $5.22M $3.27M $1.95M
2019-12-31 $11.33M $N/A $16.60M $9.32M $7.28M
2018-12-31 $4.47M $N/A $10.68M $7.60M $3.08M
2017-12-31 $604.00K $N/A $14.50M $6.62M $7.88M
2016-12-31 $10.88M $N/A $16.81M $5.66M $11.15M
2015-12-31 $15.96M $N/A $28.25M $7.98M $20.27M
2014-12-31 $619.41K $N/A $43.07M $8.45M $34.62M
2013-12-31 $62.57K $N/A $12.67M $21.89M $-9.22M
2012-12-31 $144.75K $N/A $7.99M $11.04M $-3.04M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Oct 15, 2025 N/A N/A N/A N/A N/A N/A
Sep 15, 2025 N/A N/A N/A N/A N/A N/A
May 16, 2025 N/A N/A N/A N/A N/A N/A
May 15, 2025 N/A N/A N/A N/A N/A N/A
May 14, 2025 N/A N/A N/A N/A N/A N/A
Apr 24, 2025 N/A N/A N/A N/A N/A N/A
Apr 21, 2025 N/A N/A N/A N/A N/A N/A
Apr 11, 2025 N/A N/A N/A N/A N/A N/A
Apr 09, 2025 N/A N/A N/A N/A N/A N/A
Apr 07, 2025 N/A N/A N/A N/A N/A N/A
Apr 04, 2025 N/A N/A N/A N/A N/A N/A
Apr 02, 2025 N/A N/A N/A N/A N/A N/A
Apr 01, 2025 N/A N/A N/A N/A N/A N/A
Feb 28, 2025 N/A N/A N/A N/A N/A N/A
Nov 08, 2024 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist